Evidence map›Paper›PMID 39214534›Full record

ArticleOpen heart2024

Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.

Milan Wiedemann, Victoria Speed, Christine Cunningham, Rose Higgins, Helen J Curtis, Colm Andrews, Louis Fisher, Lisa Hopcroft, Christopher T Rentsch, Viyaasan Mahalingasivam and 24 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Open heart, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Milan WiedemannNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK milan.wiedemann@phc.ox.ax.uk.ORCID 0000-0003-1991-282X
Victoria SpeedNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Christine CunninghamNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0001-6802-7355
Rose HigginsNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Helen J CurtisNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-3429-9576
Colm AndrewsNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-2715-0562
Louis FisherNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Lisa HopcroftNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Christopher T RentschFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0002-1408-7907
Viyaasan MahalingasivamFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Laurie TomlinsonEpidemiology and Population Health, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK.ORCID 0000-0001-8848-9493
Caroline MortonNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-0783-0042
Miriam SamuelWolfson Institute of Population Health, Queen Mary University of London, London, UK.
Amelia GreenNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Christopher WoodNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Andrew D BrownNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Jon MasseyNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Caroline WaltersNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Rebecca M SmithNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Peter InglesbyNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
David EvansThe DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-1100-079X
Steven MaudeNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Iain DillinghamNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Alex J WalkerThe DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-4932-6135
Jessica MorleyNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Amir MehrkarNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-2098-1278
Seb BaconNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-6354-3454
Chris BatesTPP, Leeds, UK.ORCID 0000-0003-0113-2593
Jonathan CockburnTPP, Leeds, UK.ORCID 0000-0002-4681-4873
John ParryTPP, Leeds, UK.
Frank HesterTPP, Leeds, UK.
Richard J McManusNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Ben GoldacreNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-5127-4728
Brian MacKennaNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-3786-9063

Funding

Medical Research Council MC_PC_20030Medical Research Council MC_PC_20058Medical Research Council MC_PC_20059Wellcome Trust
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic disrupted cardiovascular disease management in primary care in England.

objectiveTo describe the impact of the pandemic on blood pressure screening and hypertension management based on a national quality of care scheme (Quality and Outcomes Framework, QOF) across key demographic, regional and clinical subgroups.

methodsWith NHS England approval, a population-based cohort study was conducted using OpenSAFELY-TPP on 25.2 million NHS patients registered at general practices (March 2019 to March 2023). We examined monthly changes in recorded blood pressure screening in the preceding 5 years in patients aged ≥45 years and recorded the hypertension prevalence and the percentage of patients treated to target (≤140/90 mmHg for patients aged ≤79 years and ≤150/90 mmHg for patients aged ≥80 years) in the preceding 12 months.

resultsThe percentage of patients aged ≥45 years who had blood pressure screening recorded in the preceding 5 years decreased from 90% (March 2019) to 85% (March 2023). Recorded hypertension prevalence was relatively stable at 15% throughout the study period. The percentage of patients with a record of hypertension treated to target in the preceding 12 months reduced from a maximum of 71% (March 2020) to a minimum of 47% (February 2021) in patients aged ≤79 years and from 85% (March 2020) to a minimum of 58% (February 2021) in patients aged ≥80 years before recovery. Blood pressure screening rates in the preceding 5 years remained stable in older people, patients with recorded learning disability or care home status.

conclusionsThe pandemic substantially disrupted hypertension management QOF indicators, which is likely attributable to general reductions of blood pressure measurement including screening. OpenSAFELY can be used to continuously monitor changes in national quality-of-care schemes to identify changes in key clinical subgroups early and support prioritisation of recovery from care disrupted by COVID-19.

Indexed as

Blood PressureCOVID-19HypertensionMass ScreeningAgedAged, 80 and overAntihypertensive AgentsBlood Pressure DeterminationEnglandFemaleHumansMaleMiddle AgedPandemicsPrevalencePrimary Health CareAntihypertensive AgentsCOVID-19HypertensionQuality of Health Care

Identifiers

PMID39214534
PMCPMC11664366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.